2014 Q2 Form 10-Q Financial Statement

#000114420414049497 Filed on August 14, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $150.0K $350.0K
YoY Change -57.14%
% of Gross Profit
Research & Development $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $11.89K $0.00
YoY Change
% of Gross Profit
Operating Expenses $161.4K $8.801K
YoY Change 1733.72% 1073.47%
Operating Profit -$161.4K -$8.801K
YoY Change 1733.72%
Interest Expense $22.50K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$22.50K
YoY Change
Pretax Income -$180.0K -$230.0K
YoY Change -21.74%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$183.9K -$8.801K
YoY Change 1989.38% 1073.47%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.27 -$0.52
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.00K
YoY Change
Cash & Equivalents $20.55K $8.908K
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $21.20K $264.5K
YoY Change -91.99%
LONG-TERM ASSETS
Property, Plant & Equipment $446.4K
YoY Change
Goodwill
YoY Change
Intangibles $457.5K $243.0K
YoY Change 88.27%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $904.0K $243.0K
YoY Change 272.0%
TOTAL ASSETS
Total Short-Term Assets $21.20K $264.5K
Total Long-Term Assets $904.0K $243.0K
Total Assets $925.2K $507.5K
YoY Change 82.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.67K
YoY Change
Accrued Expenses $0.00 $1.569K
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $910.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $973.7K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $973.7K
Total Long-Term Liabilities $0.00
Total Liabilities $970.0K $1.569K
YoY Change 61722.82%
SHAREHOLDERS EQUITY
Retained Earnings -$1.796M -$12.06K
YoY Change 14791.03%
Common Stock $1.748M $2.993K
YoY Change 58300.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$48.51K $505.9K
YoY Change
Total Liabilities & Shareholders Equity $925.2K $507.5K
YoY Change 82.3%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income -$183.9K -$8.801K
YoY Change 1989.38% 1073.47%
Depreciation, Depletion And Amortization $11.89K $0.00
YoY Change
Cash From Operating Activities -$20.00K -$240.0K
YoY Change -91.67%
INVESTING ACTIVITIES
Capital Expenditures $490.0K $230.0K
YoY Change 113.04%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$490.0K -$230.0K
YoY Change 113.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 310.0K 500.0K
YoY Change -38.0%
NET CHANGE
Cash From Operating Activities -20.00K -240.0K
Cash From Investing Activities -490.0K -230.0K
Cash From Financing Activities 310.0K 500.0K
Net Change In Cash -200.0K 30.00K
YoY Change -766.67%
FREE CASH FLOW
Cash From Operating Activities -$20.00K -$240.0K
Capital Expenditures $490.0K $230.0K
Free Cash Flow -$510.0K -$470.0K
YoY Change 8.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Use Of Estimates
UseOfEstimates
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p align="justify" style=" margin: 0px; font-family : Times New Roman; font-size: 10pt;"><strong><em>Use of Estimates</em></strong><font style=" font-size: 6pt;">&#160;</font></p> <p align="justify" style=" margin: 0px; text-indent: 48px; font-family : Times New Roman; font-size: 10pt;">In preparing these unaudited condensed consolidated financial statements in conformity with GAAP, management is required to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates and assumptions included in our condensed consolidated financial statements relate to the valuation of long-lived assets, accruals for potential liabilities, and valuation assumptions related to equity instruments and share based payments.<br/> &#160;</p> </div>
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8801 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p align="justify" style=" margin: 0px; font-family : Times New Roman; font-size: 10pt;"><strong><em>Concentration of Credit Risk</em></strong><font style=" font-size: 6pt;">&#160;</font></p> <p align="justify" style=" margin: 0px; text-indent: 48px; font-family : Times New Roman; font-size: 10pt;">The Company<font style=" font-family: 'Arial Unicode MS', 'Times New Roman';">'</font>s financial instruments that potentially expose the Company to a concentration of credit risk consist of cash, accounts payable, accrued expense and a related party payable. The Company<font style=" font-family: 'Arial Unicode MS', 'Times New Roman';">'</font>s cash is deposited at a financial institution and insured by the Federal Deposit Insurance Corporation (<font style=" font-family: 'Arial Unicode MS', 'Times New Roman';">&#147;</font>FDIC<font style=" font-family: 'Arial Unicode MS', 'Times New Roman';">&#148;</font>). At various times during the year, the Company may have exceeded this amount insured by the FDIC.<br/> &#160;</p> </div>
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
250154 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8871 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
161386 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
8801 USD
us-gaap Operating Expenses
OperatingExpenses
273670 USD
us-gaap Nature Of Operations
NatureOfOperations
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p align="justify" style=" margin: 0px; font-family : Times New Roman; font-size: 10pt;"><strong>NOTE 1 <font style=" font-family: 'Arial Unicode MS', 'Times New Roman';">&#150;</font> NATURE OF BUSINESS</strong></p> <p align="justify" style=" margin: 0px; font-family : Times New Roman; font-size: 10pt;">&#160;</p> <p align="justify" style=" margin: 0px; text-indent: 48px; font-family : Times New Roman; font-size: 10pt;">IIM Global Corporation (formerly Silverwood Acquisition Corporation) ("IIM Global" or the "Company") was incorporated on September 21, 2011 under the laws of the State of Delaware to engage in any lawful corporate undertaking, including, but not limited to, selected mergers and acquisitions. IIM Global has been in the developmental stage since inception. In addition to a change in control of its management and shareholders, the Company's operations to date have been limited to issuing shares and filing a registration statement on Form <font>10</font> pursuant to the Securities Exchange Act of <font>1934</font>. IIM Global was formed to provide a method for a foreign or domestic private company to become a reporting company with a class of securities registered under the Securities Exchange Act of <font>1934</font>.</p> <p align="justify" style=" margin: 0px; font-family : Times New Roman; font-size: 10pt;">&#160;</p> <p style=" margin: 0px; font-family : Times New Roman; font-size: 10pt;"><strong><em>Going Concern</em></strong></p> <p style=" margin: 0px; text-indent: 48px; font-family : Times New Roman; font-size: 10pt;">The Company has an accumulated deficit of $<font>1,796,454</font> as of June 30, 2014. The Company<font style=" font-family: 'Arial Unicode MS', 'Times New Roman';">'</font>s continuation as a going concern is dependent on its ability to generate sufficient cash flows from operations to meet its obligations, which it has not been able to accomplish to date, and /or obtain additional financing from its stockholders and/or other third parties.</p> <p style=" margin: 0px; font-family : Times New Roman; font-size: 10pt;">&#160;</p> <p align="justify" style=" margin: 0px; text-indent: 48px; font-family : Times New Roman; font-size: 10pt;">These unaudited condensed consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to meet its obligations and continue its operations for the next fiscal year. The continuation of the Company as a going concern is dependent upon financial support from its stockholders, the ability of the Company to obtain necessary equity financing to continue operations, successfully locating and negotiating with other business entities for potential acquisition and /or acquiring new clients to generate revenues.<br/> &#160;</p> <p style=" margin: 0px; text-indent: 48px; font-family : Times New Roman; font-size: 10pt;">Management and shareholders used their personal funds to pay for certain expenses incurred by the Company in <font>2014</font>. There is <font>no</font> assurance that the Company will ever be profitable. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.</p> <p style=" margin: 0px; font-family : Times New Roman; font-size: 10pt;">&#160;</p> <div> <p style=" margin: 0px; font-family : Times New Roman; font-size: 10pt;"><strong><em>Principles of Consolidation</em></strong></p> <p style=" margin: 0px; text-indent: 48px; font-family : Times New Roman; font-size: 10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles and include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.<br/> &#160;</p> </div> <div> <p align="justify" style=" margin: 0px; font-family : Times New Roman; font-size: 10pt;"><strong><em>Use of Estimates</em></strong><font style=" font-size: 6pt;">&#160;</font></p> <p align="justify" style=" margin: 0px; text-indent: 48px; font-family : Times New Roman; font-size: 10pt;">In preparing these unaudited condensed consolidated financial statements in conformity with GAAP, management is required to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates and assumptions included in our condensed consolidated financial statements relate to the valuation of long-lived assets, accruals for potential liabilities, and valuation assumptions related to equity instruments and share based payments.<br/> &#160;</p> </div> <div> <p align="justify" style=" margin: 0px; font-family : Times New Roman; font-size: 10pt;"><strong><em>Concentration of Credit Risk</em></strong><font style=" font-size: 6pt;">&#160;</font></p> <p align="justify" style=" margin: 0px; text-indent: 48px; font-family : Times New Roman; font-size: 10pt;">The Company<font style=" font-family: 'Arial Unicode MS', 'Times New Roman';">'</font>s financial instruments that potentially expose the Company to a concentration of credit risk consist of cash, accounts payable, accrued expense and a related party payable. The Company<font style=" font-family: 'Arial Unicode MS', 'Times New Roman';">'</font>s cash is deposited at a financial institution and insured by the Federal Deposit Insurance Corporation (<font style=" font-family: 'Arial Unicode MS', 'Times New Roman';">&#147;</font>FDIC<font style=" font-family: 'Arial Unicode MS', 'Times New Roman';">&#148;</font>). At various times during the year, the Company may have exceeded this amount insured by the FDIC.<br/> &#160;</p> </div> <div> <p align="justify" style=" margin: 0px; font-family : Times New Roman; font-size: 10pt;"><strong><em>Income Taxes</em>&#160;</strong></p> <p style=" margin: 0px; text-indent: 48px; font-family : Times New Roman; font-size: 10pt;">The Company accounts for income taxes under Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) <font>740</font> <font style=" font-family: 'Arial Unicode MS', 'Times New Roman';">&#147;</font><em>Income Taxes.<font style=" font-family: 'Arial Unicode MS', 'Times New Roman';">&#148;</font>&#160;</em>Under the asset and liability method of FASB ASC <font>740</font>, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under FASB ASC <font>740</font>, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations.</p> </div> <p style=" margin: 0px; font-family : Times New Roman; font-size: 10pt;">&#160;</p> </div>
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 USD
us-gaap Depreciation
Depreciation
10829 USD
CY2014Q2 us-gaap Sale Leaseback Transaction Amount Due Under Financing Arrangement
SaleLeasebackTransactionAmountDueUnderFinancingArrangement
430000 USD
CY2014Q2 us-gaap Deposit Assets
DepositAssets
100000 USD
CY2014Q2 us-gaap Deposit Assets
DepositAssets
100000 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
50510 USD
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
16175 USD
us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
3000 USD
us-gaap Sale Leaseback Transaction Rent Expense
SaleLeasebackTransactionRentExpense
15180 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
117994 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
446447 USD
us-gaap Sale Leaseback Transaction Rent Expense
SaleLeasebackTransactionRentExpense
0 USD
CY2013Q2 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
128456 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
USD
CY2014Q2 us-gaap Cash
Cash
20554 USD
CY2013Q4 us-gaap Cash
Cash
5349 USD
CY2014Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
645 USD
CY2013Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
112645 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
21199 USD
CY2014Q2 us-gaap Debt Current
DebtCurrent
910000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
USD
us-gaap Gross Profit
GrossProfit
USD
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
USD
us-gaap Depreciation
Depreciation
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2014Q2 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
0 USD
CY2014Q2 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
0 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12687 USD
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2014Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
USD
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
27672 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19638 USD
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4491 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26069 USD
CY2014Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
31505 USD
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4803 USD
CY2014Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
63668 USD
us-gaap Interest Expense
InterestExpense
USD
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11891 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23516 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
149495 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8801 USD
CY2014Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
-273670 USD
CY2014Q2 us-gaap Purchase Obligation
PurchaseObligation
430000 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
USD
us-gaap Gross Profit
GrossProfit
USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
160623289 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1500000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
160623289 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1500000 shares
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
USD
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
USD
us-gaap Operating Expenses
OperatingExpenses
8871 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-161386 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
22500 USD
us-gaap Interest Expense
InterestExpense
32050 USD
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-22500 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-32050 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-183886 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-8801 USD
us-gaap Net Income Loss
NetIncomeLoss
-305720 USD
us-gaap Net Income Loss
NetIncomeLoss
-8871 USD
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
us-gaap Operating Income Loss
OperatingIncomeLoss
-8871 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38011 USD
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
457508 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
392501 USD
CY2014Q2 us-gaap Assets
Assets
925154 USD
CY2013Q4 us-gaap Assets
Assets
548506 USD
CY2013Q4 us-gaap Debt Current
DebtCurrent
224615 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
973668 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
291300 USD
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
160623289 shares
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
16062 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
16062 USD
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1731878 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1731878 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1796454 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1490734 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
-48514 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
257206 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
925154 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
548506 USD
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
160623289 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
160623289 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
160623289 shares
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3006 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1219 USD
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
255590 USD
ck0001534154 Increase Decrease In Security Deposits Assets
IncreaseDecreaseInSecurityDepositsAssets
112000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-173210 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-263242 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
419266 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
77694 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
243000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-496960 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-243000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
515000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
910010 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
224625 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
685385 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
515000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
15205 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8758 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5349 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
150 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20554 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8908 USD
us-gaap Interest Paid
InterestPaid
22500 USD
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
USD
us-gaap Interest Paid
InterestPaid
USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
529156 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
448320 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
71648 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
55819 USD
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
505316 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
457508 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
392501 USD
dei Entity Registrant Name
EntityRegistrantName
IIM Global Corp
dei Entity Central Index Key
EntityCentralIndexKey
0001534154
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2

Files In Submission

Name View Source Status
0001144204-14-049497-index-headers.html Edgar Link pending
0001144204-14-049497-index.html Edgar Link pending
0001144204-14-049497.txt Edgar Link pending
0001144204-14-049497-xbrl.zip Edgar Link pending
ck0001534154-20140630.xml Edgar Link completed
ck0001534154-20140630.xsd Edgar Link pending
ck0001534154-20140630_cal.xml Edgar Link unprocessable
ck0001534154-20140630_def.xml Edgar Link unprocessable
ck0001534154-20140630_lab.xml Edgar Link unprocessable
ck0001534154-20140630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v386682_10q.htm Edgar Link pending
v386682_ex31-1.htm Edgar Link pending
v386682_ex31-2.htm Edgar Link pending
v386682_ex32-1.htm Edgar Link pending
v386682_ex32-2.htm Edgar Link pending